Legal Representation
Attorney
Harold Milstein
USPTO Deadlines
Next Deadline
183 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
January 07, 2026
Extension Available
Until January 07, 2026
Application History
29 events| Date | Code | Type | Description |
|---|---|---|---|
| Jul 4, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Jul 3, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED |
| Jul 3, 2025 | EXT1 | S | SOU EXTENSION 1 FILED |
| Jul 3, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Jan 7, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Nov 26, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Nov 26, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Nov 20, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Oct 31, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| May 23, 2024 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| May 23, 2024 | CNSL | R | SUSPENSION LETTER WRITTEN |
| May 23, 2024 | GNSL | F | LETTER OF SUSPENSION E-MAILED |
| Apr 24, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Apr 23, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Apr 23, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Jan 19, 2024 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Jan 19, 2024 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Nov 17, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Nov 17, 2023 | ZZZX | Z | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Nov 17, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Nov 17, 2023 | GNRT | O | NON-FINAL ACTION E-MAILED |
| Nov 17, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Nov 13, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Nov 13, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Nov 13, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Nov 13, 2023 | DOCK | D | ASSIGNED TO EXAMINER |
| Mar 7, 2023 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Mar 4, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Feb 17, 2023 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Pharmaceutical preparations and compositions for therapeutic use and treatment in the areas of ophthalmology, neurological conditions, oncology, neurotology; pharmaceutical preparations and compositions for cell therapy treatment and transplant medicine
Additional Information
Design Mark
The mark consists of a dark blue horizontal line followed by three light blue horizontal lines followed by five light blue and orange horizontal lines, immediately followed by the stylized word "LINEAGE" in gray stacked on top of the stylized words "CELL THERAPEUTICS" in gray.
Color Claim
The color(s) dark blue, light blue, orange, and gray is/are claimed as a feature of the mark.
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"CELL THERAPEUTICS"